Shanghai announces steady progress in COVID-19 vaccine development
The development of an mRNA-based vaccine to treat the novel coronavirus disease (COVID-19) is progressing steadily with preliminary trials on primates and clinical trials expected to start in mid-April, Shanghai Science and Technology Commission told a press conference on Monday.
Click here for more.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3